169 related articles for article (PubMed ID: 28011620)
1. Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells.
Binda E; Visioli A; Giani F; Trivieri N; Palumbo O; Restelli S; Dezi F; Mazza T; Fusilli C; Legnani F; Carella M; Di Meco F; Duggal R; Vescovi AL
Cancer Res; 2017 Feb; 77(4):996-1007. PubMed ID: 28011620
[TBL] [Abstract][Full Text] [Related]
2. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
[TBL] [Abstract][Full Text] [Related]
3. MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5a.
Zhao D; Wang R; Fang J; Ji X; Li J; Chen X; Sun G; Wang Z; Liu W; Wang Y; Cheng G; Zhen H; Sun C; Fei Z
Mol Neurobiol; 2017 May; 54(4):2823-2830. PubMed ID: 27013470
[TBL] [Abstract][Full Text] [Related]
4. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis.
Singh DK; Shivalingappa PKM; Sharma A; Mondal A; Muzumdar D; Shiras A; Bapat SA
J Neurooncol; 2022 May; 157(3):575-591. PubMed ID: 35430703
[TBL] [Abstract][Full Text] [Related]
5. Role of Wnt5a in the proliferation of human glioblastoma cells.
Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS
Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.
Hu B; Wang Q; Wang YA; Hua S; Sauvé CG; Ong D; Lan ZD; Chang Q; Ho YW; Monasterio MM; Lu X; Zhong Y; Zhang J; Deng P; Tan Z; Wang G; Liao WT; Corley LJ; Yan H; Zhang J; You Y; Liu N; Cai L; Finocchiaro G; Phillips JJ; Berger MS; Spring DJ; Hu J; Sulman EP; Fuller GN; Chin L; Verhaak RGW; DePinho RA
Cell; 2016 Nov; 167(5):1281-1295.e18. PubMed ID: 27863244
[TBL] [Abstract][Full Text] [Related]
7. Daam1 activates RhoA to regulate Wnt5a‑induced glioblastoma cell invasion.
Liu G; Yan T; Li X; Sun J; Zhang B; Wang H; Zhu Y
Oncol Rep; 2018 Feb; 39(2):465-472. PubMed ID: 29207169
[TBL] [Abstract][Full Text] [Related]
8. Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups.
Kim Y; Hong M; Do IG; Ha SY; Lee D; Suh YL
Pathol Res Pract; 2015 Dec; 211(12):963-72. PubMed ID: 26596412
[TBL] [Abstract][Full Text] [Related]
9. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.
Jin X; Jeon HY; Joo KM; Kim JK; Jin J; Kim SH; Kang BG; Beck S; Lee SJ; Kim JK; Park AK; Park WY; Choi YJ; Nam DH; Kim H
Cancer Res; 2011 Apr; 71(8):3066-75. PubMed ID: 21363911
[TBL] [Abstract][Full Text] [Related]
10. Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells.
Jung EH; Lee HN; Han GY; Kim MJ; Kim CW
Cell Biochem Funct; 2016 Apr; 34(3):149-57. PubMed ID: 26923195
[TBL] [Abstract][Full Text] [Related]
11. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
12. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
[TBL] [Abstract][Full Text] [Related]
13. Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication.
Iwadate Y
Neurol Med Chir (Tokyo); 2018 Feb; 58(2):61-70. PubMed ID: 29129882
[TBL] [Abstract][Full Text] [Related]
14. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells.
Kanzawa M; Semba S; Hara S; Itoh T; Yokozaki H
Pathobiology; 2013; 80(5):235-44. PubMed ID: 23615002
[TBL] [Abstract][Full Text] [Related]
15. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition.
Ren D; Minami Y; Nishita M
Genes Cells; 2011 Mar; 16(3):304-15. PubMed ID: 21342370
[TBL] [Abstract][Full Text] [Related]
16. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells.
Jiang X; Yan Y; Hu M; Chen X; Wang Y; Dai Y; Wu D; Wang Y; Zhuang Z; Xia H
J Neurosurg; 2016 Jan; 124(1):129-36. PubMed ID: 26274999
[TBL] [Abstract][Full Text] [Related]
17. Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells.
Hall AW; Battenhouse AM; Shivram H; Morris AR; Cowperthwaite MC; Shpak M; Iyer VR
Cancer Res; 2018 May; 78(10):2463-2474. PubMed ID: 29549165
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma and stem cells.
Altaner C
Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
[TBL] [Abstract][Full Text] [Related]
19. Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells.
Webster MR; Xu M; Kinzler KA; Kaur A; Appleton J; O'Connell MP; Marchbank K; Valiga A; Dang VM; Perego M; Zhang G; Slipicevic A; Keeney F; Lehrmann E; Wood W; Becker KG; Kossenkov AV; Frederick DT; Flaherty KT; Xu X; Herlyn M; Murphy ME; Weeraratna AT
Pigment Cell Melanoma Res; 2015 Mar; 28(2):184-95. PubMed ID: 25407936
[TBL] [Abstract][Full Text] [Related]
20. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
